Motif ID: Zbtb4
Z-value: 0.726
Transcription factors associated with Zbtb4:
Gene Symbol | Entrez ID | Gene Name |
---|---|---|
Zbtb4 | ENSMUSG00000018750.8 | Zbtb4 |
Activity-expression correlation:
Gene Symbol | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Zbtb4 | mm10_v2_chr11_+_69765970_69766027 | 0.57 | 1.9e-06 | Click! |
Top targets:
Gene overrepresentation in biological_process category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 5.2 | GO:2001139 | negative regulation of postsynaptic membrane organization(GO:1901627) negative regulation of dendritic spine maintenance(GO:1902951) negative regulation of phospholipid efflux(GO:1902999) regulation of lipid transport across blood brain barrier(GO:1903000) negative regulation of lipid transport across blood brain barrier(GO:1903001) positive regulation of lipid transport across blood brain barrier(GO:1903002) negative regulation of phospholipid transport(GO:2001139) |
1.2 | 5.8 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
1.1 | 3.2 | GO:0030070 | insulin processing(GO:0030070) |
0.9 | 6.1 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.6 | 2.9 | GO:1900170 | negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
0.5 | 2.1 | GO:0097494 | regulation of vesicle size(GO:0097494) |
0.5 | 2.0 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.5 | 4.8 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.4 | 1.3 | GO:0048352 | neural plate mediolateral regionalization(GO:0021998) mesoderm structural organization(GO:0048338) paraxial mesoderm structural organization(GO:0048352) |
0.4 | 0.9 | GO:0072179 | nephric duct formation(GO:0072179) |
0.4 | 1.3 | GO:0072076 | hyaluranon cable assembly(GO:0036118) nephrogenic mesenchyme development(GO:0072076) negative regulation of glomerular mesangial cell proliferation(GO:0072125) negative regulation of glomerulus development(GO:0090194) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.4 | 1.3 | GO:0045349 | regulation of dendritic cell cytokine production(GO:0002730) interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) positive regulation of interferon-beta biosynthetic process(GO:0045359) |
0.4 | 2.1 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.4 | 1.1 | GO:0010636 | positive regulation of mitochondrial fusion(GO:0010636) |
0.3 | 1.0 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.3 | 2.0 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.3 | 5.4 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.3 | 1.7 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.2 | 1.5 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.2 | 1.4 | GO:0032804 | negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) |
0.2 | 0.9 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.2 | 0.8 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) regulation of membrane tubulation(GO:1903525) |
0.2 | 1.6 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.2 | 1.5 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.2 | 1.4 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.2 | 3.7 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.2 | 0.7 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
0.2 | 0.5 | GO:0014877 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.2 | 4.6 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.2 | 0.8 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) |
0.1 | 0.4 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) activation of meiosis involved in egg activation(GO:0060466) |
0.1 | 0.7 | GO:0097116 | gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
0.1 | 1.6 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.1 | 0.7 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.1 | 1.2 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.1 | 0.4 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.1 | 0.3 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
0.1 | 2.3 | GO:0008209 | androgen metabolic process(GO:0008209) |
0.1 | 0.7 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.1 | 0.5 | GO:0042045 | epithelial fluid transport(GO:0042045) |
0.1 | 0.3 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.1 | 0.4 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.1 | 3.0 | GO:0009214 | cyclic nucleotide catabolic process(GO:0009214) |
0.1 | 1.8 | GO:0097320 | membrane tubulation(GO:0097320) |
0.1 | 1.3 | GO:0001516 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.1 | 1.9 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
0.1 | 1.7 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.1 | 3.1 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
0.1 | 0.5 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.1 | 0.3 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.1 | 1.0 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
0.1 | 0.2 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
0.0 | 3.7 | GO:0046847 | filopodium assembly(GO:0046847) |
0.0 | 0.4 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
0.0 | 0.2 | GO:0031033 | myosin filament organization(GO:0031033) |
0.0 | 0.7 | GO:0016926 | protein desumoylation(GO:0016926) |
0.0 | 0.3 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.0 | 0.4 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.0 | 0.9 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.0 | 0.4 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.0 | 0.3 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.0 | 0.7 | GO:0014898 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.0 | 0.7 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 0.6 | GO:0032438 | melanosome organization(GO:0032438) anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.0 | 0.7 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.0 | 0.8 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.0 | 0.2 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.0 | 0.2 | GO:0002643 | regulation of tolerance induction(GO:0002643) |
0.0 | 0.1 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.0 | 0.4 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.0 | 0.5 | GO:0002076 | osteoblast development(GO:0002076) |
0.0 | 0.4 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
0.0 | 0.3 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.0 | 0.3 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.0 | 0.5 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) |
0.0 | 1.0 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
0.0 | 0.7 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.0 | 0.3 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.0 | 0.6 | GO:1901998 | toxin transport(GO:1901998) |
0.0 | 0.2 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.0 | 0.7 | GO:0002011 | morphogenesis of an epithelial sheet(GO:0002011) |
0.0 | 1.6 | GO:0007224 | smoothened signaling pathway(GO:0007224) |
Gene overrepresentation in cellular_component category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 5.2 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.6 | 4.5 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.5 | 5.1 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.5 | 1.5 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.5 | 2.0 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
0.3 | 3.4 | GO:0043083 | synaptic cleft(GO:0043083) |
0.2 | 0.7 | GO:0042642 | actomyosin, myosin complex part(GO:0042642) |
0.2 | 0.7 | GO:0031230 | intrinsic component of cell outer membrane(GO:0031230) integral component of cell outer membrane(GO:0045203) |
0.2 | 2.5 | GO:0031045 | dense core granule(GO:0031045) |
0.2 | 1.8 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.1 | 0.8 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.1 | 0.5 | GO:1902636 | kinociliary basal body(GO:1902636) |
0.1 | 1.1 | GO:0070369 | beta-catenin-TCF7L2 complex(GO:0070369) |
0.1 | 1.3 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 0.5 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.1 | 2.1 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.1 | 1.3 | GO:0097470 | ribbon synapse(GO:0097470) |
0.0 | 0.8 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.0 | 0.5 | GO:0016589 | NURF complex(GO:0016589) |
0.0 | 5.7 | GO:0016607 | nuclear speck(GO:0016607) |
0.0 | 2.7 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 3.7 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 0.6 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.0 | 0.4 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.0 | 2.3 | GO:0043195 | terminal bouton(GO:0043195) |
0.0 | 8.7 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.0 | 1.7 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 1.9 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 0.3 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.0 | 1.3 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.3 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 0.9 | GO:0014704 | intercalated disc(GO:0014704) |
0.0 | 1.2 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.0 | 0.4 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 0.3 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.0 | 0.4 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.3 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.0 | 0.2 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
Gene overrepresentation in molecular_function category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 5.2 | GO:0046911 | hydroxyapatite binding(GO:0046848) metal chelating activity(GO:0046911) phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
1.5 | 5.9 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
1.2 | 3.7 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.7 | 2.9 | GO:0038049 | glucocorticoid receptor activity(GO:0004883) transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
0.5 | 3.4 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.4 | 1.6 | GO:0042806 | fucose binding(GO:0042806) |
0.4 | 1.4 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) phospholipase A2 inhibitor activity(GO:0019834) |
0.3 | 1.3 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) prostaglandin-E synthase activity(GO:0050220) |
0.3 | 1.7 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.3 | 1.2 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.3 | 0.8 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.3 | 5.8 | GO:0032183 | SUMO binding(GO:0032183) |
0.2 | 2.5 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.2 | 0.9 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.2 | 5.2 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.2 | 1.3 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.2 | 1.1 | GO:0008808 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.2 | 1.5 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.2 | 1.3 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.2 | 0.9 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 0.9 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.1 | 1.3 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 0.7 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
0.1 | 0.7 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 1.7 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.1 | 0.4 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
0.1 | 4.6 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 2.3 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 0.7 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.1 | 0.4 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
0.1 | 1.4 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.1 | 0.7 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 0.3 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.1 | 1.0 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 0.5 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 0.6 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 0.4 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) kainate selective glutamate receptor activity(GO:0015277) |
0.1 | 0.3 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.1 | 0.5 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.1 | 1.7 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.1 | 1.0 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.1 | 3.0 | GO:0004112 | cyclic-nucleotide phosphodiesterase activity(GO:0004112) |
0.1 | 0.7 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.1 | 0.4 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 1.5 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 0.7 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.0 | 0.7 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.0 | 1.2 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 5.7 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.0 | 0.2 | GO:0004092 | carnitine O-acetyltransferase activity(GO:0004092) |
0.0 | 1.4 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.4 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.0 | 0.8 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.0 | 2.1 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.5 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.0 | 1.9 | GO:0000049 | tRNA binding(GO:0000049) |
0.0 | 0.1 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.0 | 2.1 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 1.4 | GO:0035064 | methylated histone binding(GO:0035064) |
0.0 | 0.2 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.0 | 0.3 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.0 | 0.4 | GO:0043274 | phospholipase binding(GO:0043274) |
0.0 | 1.3 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 0.4 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 0.5 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 0.4 | GO:0042805 | actinin binding(GO:0042805) |
0.0 | 1.8 | GO:0017124 | SH3 domain binding(GO:0017124) |